BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7618016)

  • 1. [Radiotherapy of hypophyseal adenoma].
    Ries G
    Praxis (Bern 1994); 1995 Jul; 84(27-28):807-13. PubMed ID: 7618016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonally inactive hypophyseal adenomas: the results and late sequelae after surgery and radiotherapy].
    Grabenbauer GG; Fietkau R; Buchfelder M; Meyer M; Baumann J; Hensen J; Rummelt V; Fahlbusch R; Sauer R
    Strahlenther Onkol; 1996 Apr; 172(4):193-7. PubMed ID: 8623081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of 68 patients with pituitary adenoma treated by radiotherapy].
    Hu CS; Ying HM; Shen CY
    Ai Zheng; 2002 Oct; 21(10):1154-7. PubMed ID: 12508665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External radiotherapy of pituitary adenomas.
    Zierhut D; Flentje M; Adolph J; Erdmann J; Raue F; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):307-14. PubMed ID: 7673017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of secretory pituitary adenoma with radiation therapy.
    Clarke SD; Woo SY; Butler EB; Dennis WS; Lu H; Carpenter LS; Chiu JK; Thornby JI; Baskin DS
    Radiology; 1993 Sep; 188(3):759-63. PubMed ID: 8394591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
    van den Bergh AC; van den Berg G; Schoorl MA; Sluiter WJ; van der Vliet AM; Hoving EW; Szabó BG; Langendijk JA; Wolffenbuttel BH; Dullaart RP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):863-9. PubMed ID: 17197121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy.
    Hughes MN; Llamas KJ; Yelland ME; Tripcony LB
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1035-43. PubMed ID: 8262824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken?
    Ayuk J
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):328-31. PubMed ID: 22107606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenoma: a radiotherapeutic perspective.
    Platta CS; Mackay C; Welsh JS
    Am J Clin Oncol; 2010 Aug; 33(4):408-19. PubMed ID: 19687730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control.
    Breen P; Flickinger JC; Kondziolka D; Martinez AJ
    J Neurosurg; 1998 Dec; 89(6):933-8. PubMed ID: 9833818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does resection of pituitary adenoma and radiotherapy cure the patient's symptoms?].
    Buchfelder M
    MMW Fortschr Med; 2001 Nov; 143(44):40-2. PubMed ID: 11732395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
    Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
    Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypofunction of peripheral target-gland after radiotherapy of pituitary adenoma--an analysis of 140 cases].
    Cui SX
    Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):227-30. PubMed ID: 2174331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent pituitary adenomas after surgical resection: the role of radiation therapy.
    Kovalic JJ; Grigsby PW; Fineberg BB
    Radiology; 1990 Oct; 177(1):273-5. PubMed ID: 2399329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
    Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation dose in critical organs due to non-coplanar irradiation of the hypophysis].
    Schulte RW; Rittmann KL; Meinass HJ; Rennicke P
    Strahlenther Onkol; 1996 Sep; 172(9):501-6. PubMed ID: 8928057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fractionated stereotactic-guided radiotherapy in the treatment of pituitary adenomas].
    Cañón Rodríguez RM; Ortiz de Urbina D; Viera JC; Beltrán C; Puebla F; García Berrocal MI; Mañas A; Peraza C; Calvo FA
    Clin Transl Oncol; 2005 Nov; 7(10):447-54. PubMed ID: 16373053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort.
    Astradsson A; Munck Af Rosenschöld P; Feldt-Rasmussen U; Poulsgaard L; Wiencke AK; Ohlhues L; Engelholm SA; Broholm H; Hansen Møller E; Klose M; Roed H; Juhler M
    Acta Oncol; 2017 Mar; 56(3):415-421. PubMed ID: 28084862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.